The Women’s Health Market was valued at ~$38 billion in 2021 and is expected to grow at a CAGR of over ~4.5% to cross $47 billion by 2026. This growth will be fueled by the rising prevalence of women-centric diseases (such as endometriosis, osteoporosis, breast cancer, menopause), the introduction of innovative new products for women’s health, government initiatives to curb population growth, and growing demand for contraceptives to avoid unwanted pregnancies.